Table 1 Lead SNPs of GWAS significant loci in the combined analysis for patients with vertigo in Taiwan

From: A genome-wide association study identifies novel loci of vertigo in an Asian population-based cohort

SNP

Chr

Position

Gene

Minor allele

Stage

MAF (case, control)

OR

95% CI

P valuea

rs6450850

rs6859527

5

5

31,529,199

31,529,192

DROSHA

T

1

(0.134, 0.184)

0.690

0.642‒0.741

3.53 × 10−23

2

(0.141, 0.185)

0.727

0.667‒0.793

1.75 × 10−12

Com

(0.137, 0.184)

0.704

0.666‒0.744

2.90 × 10−33

rs295402

19

23,334,765

ZNF91

G

1

(0.439, 0.400)

1.175

1.118‒1.234

2.49 × 10−10

2

(0.445, 0.406)

1.171

1.103‒1.244

4.55 × 10−7

Com

(0.442, 0.401)

1.172

1.129‒1.218

2.03 × 10−15

rs1234168883

5

17,221,364

BASP1

T

1

(0.026, 0.020)

1.324

1.130‒1.550

5.65 × 10−4

2

(0.030, 0.020)

1.590

1.325‒1.907

1.31 × 10−6

Com

(0.028, 0.020)

1.428

1.268‒1.609

1.31 × 10−8

  1. SNP single-nucleotide polymorphism, Chr chromosome, OR odds ratio, CI confidence interval, MAF minor allele frequency.
  2. aThe P values of logistic regression with sex, age, PC1–PC10 and SAIGE correction. The eQTL mapping was done with GTEx v.8.